Global Psychoactive Substances Market Growth (Status and Outlook) 2021-2026

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Psychoactive Substances Market Size 2016-2026

2.1.2 Psychoactive Substances Market Size CAGR by Region 2020 VS 2021 VS 2026

2.2 Psychoactive Substances Segment by Type

2.2.1 Stimulants

2.2.2 Stimulants

2.2.3 Hallucinogens

2.2.4 Depressants

2.3 Psychoactive Substances Market Size by Type

2.3.1 Global Psychoactive Substances Market Size CAGR by Type

2.3.2 Global Psychoactive Substances Market Size Market Share by Type (2016-2021)

2.4 Psychoactive Substances Segment by Application

2.4.1 Cancer

2.4.2 Neuropathic Disorders

2.4.3 Spasticity

2.5 Psychoactive Substances Market Size by Application

2.5.1 Global Psychoactive Substances Market Size CAGR by Application

2.5.2 Global Psychoactive Substances Market Size Market Share by Application (2016-2021)

3 Psychoactive Substances Market Size by Players

3.1 Psychoactive Substances Market Size Market Share by Players

3.1.1 Global Psychoactive Substances Revenue by Players (2019-2021E)

3.1.2 Global Psychoactive Substances Revenue Market Share by Players (2019-2021E)

3.2 Global Psychoactive Substances Key Players Head office and Products Offered

3.3 Market Concentration Rate Analysis

3.3.1 Competition Landscape Analysis

3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)

3.4 New Products and Potential Entrants

3.5 Mergers & Acquisitions, Expansion

4 Psychoactive Substances by Regions

4.1 Psychoactive Substances Market Size by Regions (2016-2021)

4.2 Americas Psychoactive Substances Market Size Growth (2016-2021)

4.3 APAC Psychoactive Substances Market Size Growth (2016-2021)

4.4 Europe Psychoactive Substances Market Size Growth (2016-2021)

4.5 Middle East & Africa Psychoactive Substances Market Size Growth (2016-2021)

5 Americas

5.1 Americas Psychoactive Substances Market Size by Country (2016-2021)

5.2 Americas Psychoactive Substances Market Size by Type (2016-2021)

5.3 Americas Psychoactive Substances Market Size by Application (2016-2021)

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Psychoactive Substances Market Size by Region (2016-2021)

6.2 APAC Psychoactive Substances Market Size by Type (2016-2021)

6.3 APAC Psychoactive Substances Market Size by Application (2016-2021)

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Psychoactive Substances by Country (2016-2021)

7.2 Europe Psychoactive Substances Market Size by Type (2016-2021)

7.3 Europe Psychoactive Substances Market Size by Application (2016-2021)

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Psychoactive Substances by Region (2016-2021)

8.2 Middle East & Africa Psychoactive Substances Market Size by Type (2016-2021)

8.3 Middle East & Africa Psychoactive Substances Market Size by Application (2016-2021)

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Global Psychoactive Substances Market Forecast

10.1 Global Psychoactive Substances Forecast by Regions (2021-2026)

10.1.1 Global Psychoactive Substances Forecast by Regions (2021-2026)

10.1.2 Americas Psychoactive Substances Forecast

10.1.3 APAC Psychoactive Substances Forecast

10.1.4 Europe Psychoactive Substances Forecast

10.1.5 Middle East & Africa Psychoactive Substances Forecast

10.2 Americas Psychoactive Substances Forecast by Countries (2021-2026)

10.2.1 United States Psychoactive Substances Market Forecast

10.2.2 Canada Psychoactive Substances Market Forecast

10.2.3 Mexico Psychoactive Substances Market Forecast

10.2.4 Brazil Psychoactive Substances Market Forecast

10.3 APAC Psychoactive Substances Forecast by Region (2021-2026)

10.3.1 China Psychoactive Substances Market Forecast

10.3.2 Japan Psychoactive Substances Market Forecast

10.3.3 Korea Psychoactive Substances Market Forecast

10.3.4 Southeast Asia Psychoactive Substances Market Forecast

10.3.5 India Psychoactive Substances Market Forecast

10.3.6 Australia Psychoactive Substances Market Forecast

10.4 Europe Psychoactive Substances Forecast by Country (2021-2026)

10.4.1 Germany Psychoactive Substances Market Forecast

10.4.2 France Psychoactive Substances Market Forecast

10.4.3 UK Psychoactive Substances Market Forecast

10.4.4 Italy Psychoactive Substances Market Forecast

10.4.5 Russia Psychoactive Substances Market Forecast

10.5 Middle East & Africa Psychoactive Substances Forecast by Region (2021-2026)

10.5.1 Egypt Psychoactive Substances Market Forecast

10.5.2 South Africa Psychoactive Substances Market Forecast

10.5.3 Israel Psychoactive Substances Market Forecast

10.5.4 Turkey Psychoactive Substances Market Forecast

10.5.5 GCC Countries Psychoactive Substances Market Forecast

10.6 Global Psychoactive Substances Forecast by Type (2021-2026)

10.7 Global Psychoactive Substances Forecast by Application (2021-2026)

11 Key Players Analysis

11.1 Zynerba Pharmaceuticals

11.1.1 Zynerba Pharmaceuticals Company Information

11.1.2 Zynerba Pharmaceuticals Psychoactive Substances Product Offered

11.1.3 Zynerba Pharmaceuticals Psychoactive Substances Revenue, Gross Margin and Market Share (2019-2021)

11.1.4 Zynerba Pharmaceuticals Main Business Overview

11.1.5 Zynerba Pharmaceuticals Latest Developments

11.2 GW Pharmaceuticals PLC.

11.2.1 GW Pharmaceuticals PLC. Company Information

11.2.2 GW Pharmaceuticals PLC. Psychoactive Substances Product Offered

11.2.3 GW Pharmaceuticals PLC. Psychoactive Substances Revenue, Gross Margin and Market Share (2019-2021)

11.2.4 GW Pharmaceuticals PLC. Main Business Overview

11.2.5 GW Pharmaceuticals PLC. Latest Developments

11.3 Enecta.

11.3.1 Enecta. Company Information

11.3.2 Enecta. Psychoactive Substances Product Offered

11.3.3 Enecta. Psychoactive Substances Revenue, Gross Margin and Market Share (2019-2021)

11.3.4 Enecta. Main Business Overview

11.3.5 Enecta. Latest Developments

11.4 Teewinot Life Sciences

11.4.1 Teewinot Life Sciences Company Information

11.4.2 Teewinot Life Sciences Psychoactive Substances Product Offered

11.4.3 Teewinot Life Sciences Psychoactive Substances Revenue, Gross Margin and Market Share (2019-2021)

11.4.4 Teewinot Life Sciences Main Business Overview

11.4.5 Teewinot Life Sciences Latest Developments

11.5 GD Pharma

11.5.1 GD Pharma Company Information

11.5.2 GD Pharma Psychoactive Substances Product Offered

11.5.3 GD Pharma Psychoactive Substances Revenue, Gross Margin and Market Share (2019-2021)

11.5.4 GD Pharma Main Business Overview

11.5.5 GD Pharma Latest Developments

11.6 Cape Bouvard Technologies Pty Ltd

11.6.1 Cape Bouvard Technologies Pty Ltd Company Information

11.6.2 Cape Bouvard Technologies Pty Ltd Psychoactive Substances Product Offered

11.6.3 Cape Bouvard Technologies Pty Ltd Psychoactive Substances Revenue, Gross Margin and Market Share (2019-2021)

11.6.4 Cape Bouvard Technologies Pty Ltd Main Business Overview

11.6.5 Cape Bouvard Technologies Pty Ltd Latest Developments

11.7 AusCann Group Holdings Pty Ltd.

11.7.1 AusCann Group Holdings Pty Ltd. Company Information

11.7.2 AusCann Group Holdings Pty Ltd. Psychoactive Substances Product Offered

11.7.3 AusCann Group Holdings Pty Ltd. Psychoactive Substances Revenue, Gross Margin and Market Share (2019-2021)

11.7.4 AusCann Group Holdings Pty Ltd. Main Business Overview

11.7.5 AusCann Group Holdings Pty Ltd. Latest Developments

11.8 Cannabics Pharmaceuticals Inc.

11.8.1 Cannabics Pharmaceuticals Inc. Company Information

11.8.2 Cannabics Pharmaceuticals Inc. Psychoactive Substances Product Offered

11.8.3 Cannabics Pharmaceuticals Inc. Psychoactive Substances Revenue, Gross Margin and Market Share (2019-2021)

11.8.4 Cannabics Pharmaceuticals Inc. Main Business Overview

11.8.5 Cannabics Pharmaceuticals Inc. Latest Developments

11.9 Alpha-CAT

11.9.1 Alpha-CAT Company Information

11.9.2 Alpha-CAT Psychoactive Substances Product Offered

11.9.3 Alpha-CAT Psychoactive Substances Revenue, Gross Margin and Market Share (2019-2021)

11.9.4 Alpha-CAT Main Business Overview

11.9.5 Alpha-CAT Latest Developments

11.10 Tilray

11.10.1 Tilray Company Information

11.10.2 Tilray Psychoactive Substances Product Offered

11.10.3 Tilray Psychoactive Substances Revenue, Gross Margin and Market Share (2019-2021)

11.10.4 Tilray Main Business Overview

11.10.5 Tilray Latest Developments

11. Cyrelian Pty Ltd.

11.11.1 Cyrelian Pty Ltd. Company Information

11.11.2 Cyrelian Pty Ltd. Psychoactive Substances Product Offered

11.11.3 Cyrelian Pty Ltd. Psychoactive Substances Revenue, Gross Margin and Market Share (2019-2021)

11.11.4 Cyrelian Pty Ltd. Main Business Overview

11.11.5 Cyrelian Pty Ltd. Latest Developments

11.12 MedReleaf Australia

11.12.1 MedReleaf Australia Company Information

11.12.2 MedReleaf Australia Psychoactive Substances Product Offered

11.12.3 MedReleaf Australia Psychoactive Substances Revenue, Gross Margin and Market Share (2019-2021)

11.12.4 MedReleaf Australia Main Business Overview

11.12.5 MedReleaf Australia Latest Developments

12 Research Findings and Conclusion

Table 1. Psychoactive Substances Market Size CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Stimulants

Table 3. Major Players of Cannabinoids

Table 4. Major Players of Hallucinogens

Table 5. Major Players of Depressants

Table 6. Psychoactive Substances Market Size CAGR by Type (2020-2026) & ($ Millions)

Table 7. Global Psychoactive Substances Market Size by Type (2016-2021) & ($ Millions)

Table 8. Global Psychoactive Substances Market Size Market Share by Type (2016-2021)

Table 9. Psychoactive Substances Market Size CAGR by Application (2016-2021) & ($ Millions)

Table 10. Global Psychoactive Substances Market Size by Application (2016-2021) & ($ Millions)

Table 11. Global Psychoactive Substances Market Size Market Share by Application (2016-2021)

Table 12. Global Psychoactive Substances Revenue by Players (2019-2021E) & ($ Millions)

Table 13. Global Psychoactive Substances Revenue Market Share by Players (2019-2021E)

Table 14. Psychoactive Substances Key Players Head office and Products Offered

Table 15. Psychoactive Substances Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)

Table 16. New Products and Potential Entrants

Table 17. Mergers & Acquisitions, Expansion

Table 18. Global Psychoactive Substances Market Size by Regions 2016-2021 & ($ Millions)

Table 19. Global Psychoactive Substances Market Size Market Share by Regions 2016-2021

Table 20. Americas Psychoactive Substances Market Size by Country (2016-2021) & ($ Millions)

Table 21. Americas Psychoactive Substances Market Size Market Share by Country (2016-2021)

Table 22. Americas Psychoactive Substances Market Size by Type (2016-2021) & ($ Millions)

Table 23. Americas Psychoactive Substances Market Size Market Share by Type (2016-2021)

Table 24. Americas Psychoactive Substances Market Size by Application (2016-2021) & ($ Millions)

Table 25. Americas Psychoactive Substances Market Size Market Share by Application (2016-2021)

Table 26. APAC Psychoactive Substances Market Size by Region (2016-2021) & ($ Millions)

Table 27. APAC Psychoactive Substances Market Size Market Share by Region (2016-2021)

Table 28. APAC Psychoactive Substances Market Size by Type (2016-2021) & ($ Millions)

Table 29. APAC Psychoactive Substances Market Size Market Share by Type (2016-2021)

Table 30. APAC Psychoactive Substances Market Size by Application (2016-2021) & ($ Millions)

Table 31. APAC Psychoactive Substances Market Size Market Share by Application (2016-2021)

Table 32. Europe Psychoactive Substances Market Size by Country (2016-2021) & ($ Millions)

Table 33. Europe Psychoactive Substances Market Size Market Share by Country (2016-2021)

Table 34. Europe Psychoactive Substances Market Size by Type (2016-2021) & ($ Millions)

Table 35. Europe Psychoactive Substances Market Size Market Share by Type (2016-2021)

Table 36. Europe Psychoactive Substances Market Size by Application (2016-2021) & ($ Millions)

Table 37. Europe Psychoactive Substances Market Size Market Share by Application (2016-2021)

Table 38. Middle East & Africa Psychoactive Substances Market Size by Region (2016-2021) & ($ Millions)

Table 39. Middle East & Africa Psychoactive Substances Market Size Market Share by Region (2016-2021)

Table 40. Middle East & Africa Psychoactive Substances Market Size by Type (2016-2021) & ($ Millions)

Table 41. Middle East & Africa Psychoactive Substances Market Size Market Share by Type (2016-2021)

Table 42. Middle East & Africa Psychoactive Substances Market Size by Application (2016-2021) & ($ Millions)

Table 43. Middle East & Africa Psychoactive Substances Market Size Market Share by Application (2016-2021)

Table 44. Key and Potential Regions of Psychoactive Substances

Table 45. Key Application and Potential Industries of Psychoactive Substances

Table 46. Key Challenges of Psychoactive Substances

Table 47. Key Trends of Psychoactive Substances

Table 48. Global Psychoactive Substances Market Size Forecast by Regions (2021-2026) & ($ Millions)

Table 49. Global Psychoactive Substances Market Size Market Share Forecast by Regions (2021-2026)

Table 50. Global Psychoactive Substances Market Size Forecast by Type (2021-2026) & ($ Millions)

Table 51. Global Psychoactive Substances Market Size Market Share Forecast by Type (2021-2026)

Table 52. Global Psychoactive Substances Market Size Forecast by Application (2021-2026) & ($ Millions)

Table 53. Global Psychoactive Substances Market Size Market Share Forecast by Application (2021-2026)

Table 54. Zynerba Pharmaceuticals Details, Company Type, Psychoactive Substances Area Served and Its Competitors

Table 55. Zynerba Pharmaceuticals Psychoactive Substances Product Offered

Table 56. Zynerba Pharmaceuticals Psychoactive Substances Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 57. Zynerba Pharmaceuticals Main Business

Table 58. Zynerba Pharmaceuticals Latest Developments

Table 59. GW Pharmaceuticals PLC. Details, Company Type, Psychoactive Substances Area Served and Its Competitors

Table 60. GW Pharmaceuticals PLC. Psychoactive Substances Product Offered

Table 61. GW Pharmaceuticals PLC. Main Business

Table 62. GW Pharmaceuticals PLC. Psychoactive Substances Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 63. GW Pharmaceuticals PLC. Latest Developments

Table 64. Enecta. Details, Company Type, Psychoactive Substances Area Served and Its Competitors

Table 65. Enecta. Psychoactive Substances Product Offered

Table 66. Enecta. Main Business

Table 67. Enecta. Psychoactive Substances Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 68. Enecta. Latest Developments

Table 69. Teewinot Life Sciences Details, Company Type, Psychoactive Substances Area Served and Its Competitors

Table 70. Teewinot Life Sciences Psychoactive Substances Product Offered

Table 71. Teewinot Life Sciences Main Business

Table 72. Teewinot Life Sciences Psychoactive Substances Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 73. Teewinot Life Sciences Latest Developments

Table 74. GD Pharma Details, Company Type, Psychoactive Substances Area Served and Its Competitors

Table 75. GD Pharma Psychoactive Substances Product Offered

Table 76. GD Pharma Main Business

Table 77. GD Pharma Psychoactive Substances Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 78. GD Pharma Latest Developments

Table 79. Cape Bouvard Technologies Pty Ltd Details, Company Type, Psychoactive Substances Area Served and Its Competitors

Table 80. Cape Bouvard Technologies Pty Ltd Psychoactive Substances Product Offered

Table 81. Cape Bouvard Technologies Pty Ltd Main Business

Table 82. Cape Bouvard Technologies Pty Ltd Psychoactive Substances Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 83. Cape Bouvard Technologies Pty Ltd Latest Developments

Table 84. AusCann Group Holdings Pty Ltd. Details, Company Type, Psychoactive Substances Area Served and Its Competitors

Table 85. AusCann Group Holdings Pty Ltd. Psychoactive Substances Product Offered

Table 86. AusCann Group Holdings Pty Ltd. Main Business

Table 87. AusCann Group Holdings Pty Ltd. Psychoactive Substances Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 88. AusCann Group Holdings Pty Ltd. Latest Developments

Table 89. Cannabics Pharmaceuticals Inc. Details, Company Type, Psychoactive Substances Area Served and Its Competitors

Table 90. Cannabics Pharmaceuticals Inc. Psychoactive Substances Product Offered

Table 91. Cannabics Pharmaceuticals Inc. Main Business

Table 92. Cannabics Pharmaceuticals Inc. Psychoactive Substances Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 93. Cannabics Pharmaceuticals Inc. Latest Developments

Table 94. Alpha-CAT Details, Company Type, Psychoactive Substances Area Served and Its Competitors

Table 95. Alpha-CAT Psychoactive Substances Product Offered

Table 96. Alpha-CAT Main Business

Table 97. Alpha-CAT Psychoactive Substances Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 98. Alpha-CAT Latest Developments

Table 99. Tilray Details, Company Type, Psychoactive Substances Area Served and Its Competitors

Table 100. Tilray Psychoactive Substances Product Offered

Table 101. Tilray Main Business

Table 102. Tilray Psychoactive Substances Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 103. Tilray Latest Developments

Table 104. Cyrelian Pty Ltd. Details, Company Type, Psychoactive Substances Area Served and Its Competitors

Table 105. Cyrelian Pty Ltd. Psychoactive Substances Product Offered

Table 106. Cyrelian Pty Ltd. Psychoactive Substances Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 107. Cyrelian Pty Ltd. Main Business

Table 108. Cyrelian Pty Ltd. Latest Developments

Table 109. MedReleaf Australia Details, Company Type, Psychoactive Substances Area Served and Its Competitors

Table 110. MedReleaf Australia Psychoactive Substances Product Offered

Table 111. MedReleaf Australia Main Business

Table 112. MedReleaf Australia Psychoactive Substances Revenue ($ million), Gross Margin and Market Share (2019-2021E)

Table 113. MedReleaf Australia Latest Developments

List of Figures

Figure 1. Psychoactive Substances Report Years Considered

Figure 2. Research Objectives

Figure 3. Research Methodology

Figure 4. Research Process and Data Source

Figure 5. Global Psychoactive Substances Market Size Growth Rate 2016-2026 ($ Millions)

Figure 6. Global Psychoactive Substances Market Size Market Share by Type in 2020

Figure 7. Psychoactive Substances in Cancer

Figure 8. Global Psychoactive Substances Market: Cancer (2016-2021) & ($ Millions)

Figure 9. Psychoactive Substances in Neuropathic Disorders

Figure 10. Global Psychoactive Substances Market: Neuropathic Disorders (2016-2021) & ($ Millions)

Figure 11. Psychoactive Substances in Spasticity

Figure 12. Global Psychoactive Substances Market: Spasticity (2016-2021) & ($ Millions)

Figure 13. Global Psychoactive Substances Market Size Market Share by Application in 2020

Figure 14. Global Psychoactive Substances Revenue Market Share by Player in 2020

Figure 15. Global Psychoactive Substances Market Size Market Share by Regions (2016-2021)

Figure 16. Americas Psychoactive Substances Market Size 2016-2021 ($ Millions)

Figure 17. APAC Psychoactive Substances Market Size 2016-2021 ($ Millions)

Figure 18. Europe Psychoactive Substances Market Size 2016-2021 ($ Millions)

Figure 19. Middle East & Africa Psychoactive Substances Market Size 2016-2021 ($ Millions)

Figure 20. Americas Psychoactive Substances Market Size Market Share by Country in 2020

Figure 21. Americas Psychoactive Substances Market Size Market Share by Type in 2020

Figure 22. Americas Psychoactive Substances Market Size Market Share by Application in 2020

Figure 23. United States Psychoactive Substances Market Size Growth 2016-2021 ($ Millions)

Figure 24. Canada Psychoactive Substances Market Size Growth 2016-2021 ($ Millions)

Figure 25. Mexico Psychoactive Substances Market Size Growth 2016-2021 ($ Millions)

Figure 26. APAC Psychoactive Substances Market Size Market Share by Regions in 2020

Figure 27. APAC Psychoactive Substances Market Size Market Share by Type in 2020

Figure 28. APAC Psychoactive Substances Market Size Market Share by Application in 2020

Figure 29. China Psychoactive Substances Market Size Growth 2016-2021 ($ Millions)

Figure 30. Japan Psychoactive Substances Market Size Growth 2016-2021 ($ Millions)

Figure 31. Korea Psychoactive Substances Market Size Growth 2016-2021 ($ Millions)

Figure 32. Southeast Asia Psychoactive Substances Market Size Growth 2016-2021 ($ Millions)

Figure 33. India Psychoactive Substances Market Size Growth 2016-2021 ($ Millions)

Figure 34. Australia Psychoactive Substances Market Size Growth 2016-2021 ($ Millions)

Figure 35. Europe Psychoactive Substances Market Size Market Share by Country in 2020

Figure 36. Europe Psychoactive Substances Market Size Market Share by Type in 2020

Figure 37. Europe Psychoactive Substances Market Size Market Share by Application in 2020

Figure 38. Germany Psychoactive Substances Market Size Growth 2016-2021 ($ Millions)

Figure 39. France Psychoactive Substances Market Size Growth 2016-2021 ($ Millions)

Figure 40. UK Psychoactive Substances Market Size Growth 2016-2021 ($ Millions)

Figure 41. Italy Psychoactive Substances Market Size Growth 2016-2021 ($ Millions)

Figure 42. Russia Psychoactive Substances Market Size Growth 2016-2021 ($ Millions)

Figure 43. Middle East & Africa Psychoactive Substances Market Size Market Share by Region in 2020

Figure 44. Middle East & Africa Psychoactive Substances Market Size Market Share by Type in 2020

Figure 45. Middle East & Africa Psychoactive Substances Market Size Market Share by Application in 2020

Figure 46. Egypt Psychoactive Substances Market Size Growth 2016-2021 ($ Millions)

Figure 47. South Africa Psychoactive Substances Market Size Growth 2016-2021 ($ Millions)

Figure 48. Israel Psychoactive Substances Market Size Growth 2016-2021 ($ Millions)

Figure 49. Turkey Psychoactive Substances Market Size Growth 2016-2021 ($ Millions)

Figure 50. GCC Country Psychoactive Substances Market Size Growth 2016-2021 ($ Millions)

Figure 51. Americas Psychoactive Substances Market Size 2021-2026 ($ Millions)

Figure 52. APAC Psychoactive Substances Market Size 2021-2026 ($ Millions)

Figure 53. Europe Psychoactive Substances Market Size 2021-2026 ($ Millions)

Figure 54. Middle East & Africa Psychoactive Substances Market Size 2021-2026 ($ Millions)

Figure 55. United States Psychoactive Substances Market Size 2021-2026 ($ Millions)

Figure 56. Canada Psychoactive Substances Market Size 2021-2026 ($ Millions)

Figure 57. Mexico Psychoactive Substances Market Size 2021-2026 ($ Millions)

Figure 58. Brazil Psychoactive Substances Market Size 2021-2026 ($ Millions)

Figure 59. China Psychoactive Substances Market Size 2021-2026 ($ Millions)

Figure 60. Japan Psychoactive Substances Market Size 2021-2026 ($ Millions)

Figure 61. Korea Psychoactive Substances Market Size 2021-2026 ($ Millions)

Figure 62. Southeast Asia Psychoactive Substances Market Size 2021-2026 ($ Millions)

Figure 63. India Psychoactive Substances Market Size 2021-2026 ($ Millions)

Figure 64. Australia Psychoactive Substances Market Size 2021-2026 ($ Millions)

Figure 65. Germany Psychoactive Substances Market Size 2021-2026 ($ Millions)

Figure 66. France Psychoactive Substances Market Size 2021-2026 ($ Millions)

Figure 67. UK Psychoactive Substances Market Size 2021-2026 ($ Millions)

Figure 68. Italy Psychoactive Substances Market Size 2021-2026 ($ Millions)

Figure 69. Russia Psychoactive Substances Market Size 2021-2026 ($ Millions)

Figure 70. Spain Psychoactive Substances Market Size 2021-2026 ($ Millions)

Figure 71. Egypt Psychoactive Substances Market Size 2021-2026 ($ Millions)

Figure 72. South Africa Psychoactive Substances Market Size 2021-2026 ($ Millions)

Figure 73. Israel Psychoactive Substances Market Size 2021-2026 ($ Millions)

Figure 74. Turkey Psychoactive Substances Market Size 2021-2026 ($ Millions)

Figure 75. GCC Country Psychoactive Substances Market Size 2021-2026 ($ Millions)